U.S. General Merchandise and Department Stores Stock News

NYSE:INVX
NYSE:INVXEnergy Services

Innovex International (INVX) Joins Russell Indexes, Is The Upside Already Priced In?

Innovex International (INVX) has just been added to multiple Russell growth indexes. This event can reshape who holds the stock as index funds and benchmarked investors adjust their portfolios. See our latest analysis for Innovex International. Over the past year Innovex International has combined a 10.01% year to date share price gain with a 54.03% total shareholder return. However, the 30 day share price return is down 11.85%, and the recent index additions appear to be resetting near term...
NYSE:CMC
NYSE:CMCMetals and Mining

3 Value Stocks Worth A Closer Look In Today’s Expensive Market

With major indexes riding an AI-fueled surge and the Buffett indicator sitting at a very high level relative to GDP, many investors are wondering where genuine value still exists and where risks might be building. This article looks at how that backdrop could affect a group of stocks flagged by a Value Stocks screener, focusing on low P/E and P/B ratios and a possible discount to intrinsic value. Below, you will find 3 stocks that the recent market setup may treat as relative beneficiaries...
NYSE:AB
NYSE:ABCapital Markets

How AllianceBernstein’s Margin Push and Private Markets Expansion At AllianceBernstein Holding (AB) Has Changed Its Investment Story

In recent months, AllianceBernstein Holding has advanced efforts to lift profitability through office relocations and other margin accretion measures, while broadening its private markets platform via partnerships and new products in private credit, real estate, and alternative strategies. This push into higher-fee private markets and operational efficiency has sharpened investor focus on how the firm may reshape its earnings mix and risk profile. Next, we’ll examine how AllianceBernstein’s...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Microchip Technology (MCHP) Just Made Its MPLAB Pro And ML Tools Free

Microchip Technology has made its MPLAB XC Pro Compilers and Machine Learning Development Suite available for free to all users worldwide. The move also covers its functional safety compilers, broadening access to tools for safety-critical and AI-enabled embedded applications. This shift is expected to widen adoption of Microchip’s microcontroller platforms and deepen engagement with its development ecosystem. For investors watching NasdaqGS:MCHP, this software decision adds an important...
NasdaqGM:QNT
NasdaqGM:QNTIT

Quantinuum (QNT) Stock Still Looks Cheap Against Fair Value

After a strong first month as a public company, Quantinuum’s near 30% gain over the past 30 days sits alongside a sharp split in valuation signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market based multiples screen the stock as expensive. The question for investors is how to weigh that tension against early stage quantum computing expectations and the stock’s low overall value score. Quantinuum has risen 29.5% over the past month,...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Does Viking Therapeutics (VKTX) Expanding Into Dual-Agonist Obesity Drugs Reframe Its Long-Term Pipeline Strategy?

Earlier this year, Viking Therapeutics began a Phase 1 single ascending dose trial of VK3019, a dual amylin and calcitonin receptor agonist being tested as a potential obesity treatment in adults with excess weight. This first-in-human study expands Viking’s obesity pipeline beyond its GLP‑1/GIP program, highlighting a multi-mechanism approach that could broaden its future treatment profile if development progresses successfully. We’ll now examine how adding VK3019 as an early-stage obesity...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Is Avnet’s Index Exit and Value Re‑Rating Altering The Investment Case For AVT?

In late June 2026, Avnet, Inc. (NasdaqGS: AVT) was removed from both the Russell 1000 Defensive and Russell 1000 Value-Defensive indices, reflecting a reclassification of the stock within those benchmarks. At the same time, research commentary highlighting Avnet’s attractive valuation metrics and positive earnings outlook has drawn fresh attention to the company as a potential value opportunity. Next, we’ll examine how Avnet’s index removal, alongside its perceived undervaluation and...
NYSE:KGS
NYSE:KGSEnergy Services

Is Kodiak Gas Services (KGS) Cheap After Its Baker Hughes Power Deal?

Kodiak Gas Services (KGS) is in focus after agreeing to a multi year power generation deal with Baker Hughes that targets up to 1.8 gigawatts of behind the meter capacity for growing AI and data center demand. See our latest analysis for Kodiak Gas Services. The Baker Hughes agreement follows Kodiak Gas Services joining the Russell 2000 Growth Defensive and Defensive Indexes in late June. It also comes alongside strong momentum, with an 85.6% year-to-date share price return and a 3-year total...
NYSE:PLD
NYSE:PLDIndustrial REITs

Prologis (PLD) Presses SEGRO Shareholders As Takeover Resistance Drags On

Prologis (NYSE:PLD) has taken its proposed all stock combination with SEGRO public, releasing a new presentation to SEGRO shareholders. The company is urging SEGRO investors to press their board to enter takeover talks, while SEGRO's board continues to resist the deal. This move shifts the discussion from private boardroom talks to a wider shareholder audience, highlighting Prologis' commitment to a public engagement campaign. Prologis enters this phase of the saga with its stock at $141.0...
NYSE:LNN
NYSE:LNNMachinery

Lindsay (LNN) Stock Still Looks Cheap Despite a 26% Slide

Lindsay stock is coming off a challenging stretch, with the share price down about 26% over 5 years, yet the current intrinsic value estimate from a Discounted Cash Flow (DCF) model points to meaningful upside compared with where the market is pricing it today. At the same time, earnings based multiples look roughly in line with peers, which sets up a tension between a seemingly cheap cash flow profile and a share price that does not screen as obviously mispriced on simpler metrics. Over 5...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Precigen (PGEN) In Focus As Russell Removal Tests Its Undervalued Narrative

Index removal puts Precigen stock in focus Precigen (PGEN) has been removed from several Russell value and small cap benchmarks, an index reshuffle that can prompt passive funds to rebalance and temporarily change trading volumes or pricing. See our latest analysis for Precigen. For context, Precigen's share price has a 30 day share price return of 55.74% and a year to date share price return of 29.91%, while the 1 year total shareholder return of 192.63% and 3 year total shareholder return...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya (PGY) Expands Upgrade Partnership Into Buy Now Pay Later For Travel

Pagaya Technologies and Upgrade have expanded their partnership to bring Pagaya’s AI-driven credit decisioning to Buy Now, Pay Later offerings. The collaboration targets BNPL solutions for travel merchants, broadening Pagaya’s reach beyond personal loans. The development highlights a move into new asset classes for Pagaya’s platform, with potential implications for its client mix and revenue sources. Pagaya Technologies (NasdaqCM:PGY) is drawing fresh attention as it extends its AI credit...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Opens East Asia Routes With First Air Premia Partnership

Southwest Airlines and Korean carrier Air Premia have entered into their first-ever interline partnership. The agreement connects Air Premia routes from South Korea with more than 120 destinations across the Southwest Airlines network. The partnership opens new East Asia connectivity for Southwest customers and expands options for travelers originating in South Korea. For investors watching Southwest Airlines, ticker NYSE:LUV, this partnership introduces an additional international angle to...
NYSE:WHD
NYSE:WHDEnergy Services

Cactus (WHD) Stock Looks Strong On Returns Yet Rich On Earnings

Cactus stock has delivered a solid 49.9% return over the past five years, yet current valuation checks suggest the shares are not an obvious bargain at recent levels. With the latest move putting the stock at US$53.73 and broader value indicators leaning expensive, investors are weighing whether the recent performance still leaves enough room for attractive future returns. Over the past five years, Cactus has returned 49.9%, which sets a relatively high bar for what investors might...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Monte Rosa Therapeutics (GLUE) Recast As A Growth Name As Valuation Questions Build

Monte Rosa Therapeutics (GLUE) is in focus after a broad reshuffle of its index affiliations, as the stock was added to several Russell growth benchmarks while being removed from multiple value oriented Russell indexes. See our latest analysis for Monte Rosa Therapeutics. The index reshuffle comes after a sharp run in Monte Rosa Therapeutics' share price, with a 30 day share price return of 41.53% and a year to date share price return of 57.15%, alongside a one year total shareholder return...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Personalis (PSNL) Stock Looks Rich Even After A Very Large Run

Personalis stock has delivered a very large 3 year gain, yet the valuation checks still lean expensive, which puts the recent share price strength in tension with what the broader numbers suggest about value. Over the past 3 years, Personalis has returned roughly 5x, which is a very large move that raises the bar for what the current share price needs to justify. Future revenue growth and the path to stronger, more consistent cash flows can support today’s valuation. However, execution risks...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Stock May Be Fully Priced As Shield Coverage Expands

Guardant Health stock has delivered an exceptionally strong 3 year return, yet its valuation checks are pulling in different directions, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade below intrinsic value while market based multiples point to an expensive profile. Over the past 3 years Guardant Health has returned 313.6%, which puts added focus on whether the current price still aligns with the underlying cash flow outlook. Expanded coverage for the...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Stock Still Looks Below Fair Value Today

Halliburton stock has delivered a 79.3% return over the past five years, and the current checks still suggest the shares lean cheap rather than fully priced in. With fresh contracts in Iraq and mixed short term trading, investors are weighing how much of the story is already reflected in the valuation. A 79.3% five year return points to solid longer term shareholder gains, raising the question of how much upside may already be captured in Halliburton's current price. The recent agreement to...
NYSE:DLX
NYSE:DLXCommercial Services

How Investors May Respond To Deluxe (DLX) Joining Russell 2000 Defensive and Value-Defensive Indices

In June 2026, Deluxe Corporation (NYSE: DLX) was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, highlighting its classification as a smaller-cap company with more defensive, value-oriented characteristics. This dual index inclusion can influence how institutional investors view Deluxe, potentially affecting demand for the shares as index-tracking funds and quantitatively driven portfolios adjust their holdings. Next, we’ll examine how Deluxe’s...
NasdaqGS:CBC
NasdaqGS:CBCBanks

Is Central Bancompany’s Shift Into Russell Defensive Indices Reframing The Investment Case For CBC?

On 27 June 2026, Central Bancompany, Inc. was removed from the Russell 1000 Dynamic Index and added to the Russell 1000 Value-Defensive and Russell 1000 Defensive indices, reshaping its index footprint among large-cap US equities. This reclassification into defensive-oriented benchmarks may influence how institutional investors perceive the bank’s risk profile and adjust their portfolio allocations. Now we’ll explore how Central Bancompany’s shift into Russell 1000 defensive indices affects...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Company (DCI) Faces Soft Demand, Is It Still 9% Undervalued?

Donaldson Company (DCI) is back in focus after fresh analysis pointed to weak constant currency revenue growth, soft demand and declining returns on capital, raising questions around the stock’s underlying earnings power. See our latest analysis for Donaldson Company. Despite the recent concerns around Donaldson Company’s growth profile, the stock is trading at $87.68 and has eased in the short term, with the share price falling 2.1% over the last day and 1.6% over the past quarter. At the...
NYSE:WOR
NYSE:WORMachinery

Does Index Exit And Equity Grant Reshape the Bull Case For Worthington Enterprises (WOR)?

Worthington Enterprises, Inc. (NYSE: WOR) was removed from the Russell 2000 Dynamic Index on 27 June 2026, a change that can influence how index funds and benchmarked investors allocate capital to the stock. At the same time, a fresh restricted stock grant to director William Bradley Southern under the 2025 Equity Plan ties board compensation more closely to future company performance and governance continuity. We’ll now examine how Worthington’s removal from the Russell 2000 Dynamic Index...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

3 Promising Stocks Estimated To Be Up To 26.7% Below Intrinsic Value

In the last week, the United States market has stayed flat, yet over the past 12 months, it has risen by an impressive 18%, with earnings expected to grow at a similar rate annually in the coming years. In this context of steady growth and optimistic projections, identifying stocks that are trading below their intrinsic value can offer investors potential opportunities for capitalizing on undervalued assets.
NYSE:EL
NYSE:ELPersonal Products

3 Insider-Owned Growth Companies To Watch Now

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings forecasted to grow by 18% annually. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders.